Compare Across Protocol (ACX) vs Injective (INJ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Across Protocol vs Injective — how do they compare? Across Protocol trades at Rp743.31 (market cap Rp527,52M, Rp28,21M 24h volume), while Injective trades at Rp83,895 (market cap Rp8,37T, Rp1,24T 24h volume). The key difference: Injective is far larger — about 15866.7× Across Protocol 's market cap, and Across Protocol 's supply is capped (704,7M / 1B ACX (71%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Across Protocol for 54 Days and Injective for 36 Days on average.
| ACX | INJ | |
|---|---|---|
Market Cap | Rp527,52M | Rp8,37T |
Volume (24h) | Rp28,21M | Rp1,24T |
Circulating Supply | 704,7M / 1B ACX (71%) | 100M INJ |
Typical Hold Time | 54 Days | 36 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Across Protocol (ACX) is trading at Rp741.83 with a bearish technical signal, showing sell pressure from moving averages while oscillators remain neutral. The token is currently testing support near Rp731 with resistance at Rp756. With 71% of the 1 million max supply in circulation and an average hold time of 54 days, the token shows moderate distribution stability despite current bearish momentum.
The overall outlook remains cautious due to strong bearish technical indicators, though neutral oscillators suggest potential stabilization. Key opportunities include protocol utility in cross-chain bridging, while major risks involve low liquidity (Rp522.31M market cap) and crypto market volatility. Investors should monitor support levels for potential entry points.
INJ is trading at Rp83,360 with a market cap of Rp8.39T, showing neutral technical signals overall. The asset is currently positioned between key support at Rp82,799 and resistance at Rp86,949, with mixed moving average signals but neutral oscillators. Recent network activity shows an average hold time of 36 days, indicating moderate holding behavior among investors.
Outlook remains cautiously neutral with potential for movement toward resistance levels. Key opportunities include protocol ecosystem growth, while risks involve typical crypto volatility and regulatory uncertainty. Investors should monitor volume patterns and network adoption metrics for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Across Protocol
Across (ACX) is a cross-chain token bridge secured by UMA's optimistic oracle. Designed for capital efficiency, ACX features a single liquidity pool, competitive relayer options, and a no-slippage fee model. Because its oracle verifies transfers optimistically, ACX is able to process cross-chain transfers quickly.
Read more on ACX →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
